tradingkey.logo

STAAR Surgical Co

STAA
23.350USD
-0.280-1.18%
收盘 12/26, 16:00美东报价延迟15分钟
1.15B总市值
亏损市盈率 TTM

STAAR Surgical Co

23.350
-0.280-1.18%

关于 STAAR Surgical Co 公司

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

STAAR Surgical Co简介

公司代码STAA
公司名称STAAR Surgical Co
上市日期Feb 24, 1992
CEOFarrell (Stephen C)
员工数量1157
证券类型Ordinary Share
年结日Feb 24
公司地址1911 Walker Ave
城市MONROVIA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编91016
电话16263037902
网址https://www.staar.com/
公司代码STAA
上市日期Feb 24, 1992
CEOFarrell (Stephen C)

STAAR Surgical Co公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
46.54K
+82.00%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
475.00
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
46.54K
+82.00%
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
35.16K
--
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
19.31K
--
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
10.80K
--
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
9.76K
--
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
8.59K
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
Others
18.18M
41.02%
Japan
10.91M
24.63%
U. S.
5.63M
12.71%
China
5.30M
11.96%
South Korea
4.29M
9.69%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Broadwood Capital, Inc.
30.19%
BlackRock Institutional Trust Company, N.A.
13.23%
The Vanguard Group, Inc.
8.56%
Yunqi Capital Limited
5.03%
State Street Investment Management (US)
3.84%
其他
39.14%
持股股东
持股股东
占比
Broadwood Capital, Inc.
30.19%
BlackRock Institutional Trust Company, N.A.
13.23%
The Vanguard Group, Inc.
8.56%
Yunqi Capital Limited
5.03%
State Street Investment Management (US)
3.84%
其他
39.14%
股东类型
持股股东
占比
Hedge Fund
48.81%
Investment Advisor
34.47%
Investment Advisor/Hedge Fund
18.71%
Research Firm
2.92%
Pension Fund
1.13%
Bank and Trust
0.58%
Individual Investor
0.49%
Insurance Company
0.04%
Sovereign Wealth Fund
0.03%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
511
49.83M
100.45%
-14.96M
2025Q2
543
53.99M
109.59%
-5.64M
2025Q1
586
53.67M
108.47%
-5.73M
2024Q4
611
49.68M
100.75%
-8.34M
2024Q3
633
50.35M
102.36%
-6.37M
2024Q2
636
49.69M
101.15%
-10.70M
2024Q1
632
50.54M
103.45%
-9.24M
2023Q4
640
52.70M
107.96%
-9.84M
2023Q3
658
55.47M
114.38%
-3.16M
2023Q2
667
52.64M
108.92%
-2.50M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Broadwood Capital, Inc.
13.52M
27.39%
--
--
Sep 24, 2025
BlackRock Institutional Trust Company, N.A.
6.72M
13.61%
-298.81K
-4.26%
Jun 30, 2025
The Vanguard Group, Inc.
4.38M
8.88%
-1.02M
-18.96%
Jun 30, 2025
Yunqi Capital Limited
2.50M
5.07%
+88.77K
+3.68%
Sep 19, 2025
State Street Investment Management (US)
2.00M
4.06%
+7.97K
+0.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.42%
+3.33K
+0.28%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AltShares Merger Arbitrage ETF
2.71%
ProShares Merger ETF
2.53%
State Street SPDR S&P Health Care Equipment ETF
1.67%
NYLI Merger Arbitrage ETF
0.87%
Invesco S&P SmallCap Health Care ETF
0.79%
Royce Quant Small-Cap Quality Value ETF
0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
0.13%
iShares S&P Small-Cap 600 Growth ETF
0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
0.1%
iShares ESG Select Screened S&P Small-Cap ETF
0.1%
查看更多
AltShares Merger Arbitrage ETF
占比2.71%
ProShares Merger ETF
占比2.53%
State Street SPDR S&P Health Care Equipment ETF
占比1.67%
NYLI Merger Arbitrage ETF
占比0.87%
Invesco S&P SmallCap Health Care ETF
占比0.79%
Royce Quant Small-Cap Quality Value ETF
占比0.26%
State Street SPDR S&P SmallCap 600 ESG ETF
占比0.13%
iShares S&P Small-Cap 600 Growth ETF
占比0.1%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.1%
iShares ESG Select Screened S&P Small-Cap ETF
占比0.1%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

STAAR Surgical Co的前五大股东是谁?

STAAR Surgical Co 的前五大股东如下:
Broadwood Capital, Inc.持有股份:13.52M,占总股份比例:27.39%。
BlackRock Institutional Trust Company, N.A.持有股份:6.72M,占总股份比例:13.61%。
The Vanguard Group, Inc.持有股份:4.38M,占总股份比例:8.88%。
Yunqi Capital Limited持有股份:2.50M,占总股份比例:5.07%。
State Street Investment Management (US)持有股份:2.00M,占总股份比例:4.06%。

STAAR Surgical Co的前三大股东类型是什么?

STAAR Surgical Co 的前三大股东类型分别是:
Broadwood Capital, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

有多少机构持有STAAR Surgical Co(STAA)的股份?

截至2025Q3,共有511家机构持有STAAR Surgical Co的股份,合计持有的股份价值约为49.83M,占公司总股份的100.45%。与2025Q2相比,机构持股有所增加,增幅为-9.13%。

哪个业务部门对STAAR Surgical Co的收入贡献最大?

在FY2025Q2,--业务部门对STAAR Surgical Co的收入贡献最大,创收--,占总收入的--%。
KeyAI